Tina Bhutani, MD

Treat-to-Target Outcomes With Tapinarof Cream 1% in Phase 3 Trials for Plaque Psoriasis

Author:: April W. Armstrong, MD, MPH; Robert Bissonnette, MD; Raj Chovatiya, MD, PhD; Tina Bhutani, MD; Philip M. Brown, MD, JD; Anna M. Tallman, PharmD; Kim A. Papp, MD, PhD

The National Psoriasis Foundation (NPF) treatment targets aim to achieve 1% or lower body surface area (BSA) affected after 3...

Author:: Allison Kranyak, MD; Kathryn Haran, BS; Payton Smith, BS; Chandler Johnson, BA, BS; Wilson Liao, MD; Tina Bhutani, MD

The authors look at how dietary patterns such as the Mediterranean diet (MeD) and vegan/vegetarian diets—even without strong data showing benefits...

Author:: Michael Abrouk, MD; Mio Nakamura, MD; Tian Hao Zhu, MD; Benjamin Farahnik, MD; John Koo, MD; Tina Bhutani, MD

Pityriasis rubra pilaris (PRP) is a rare inflammatory dermatosis of unknown etiology characterized by erythematosquamous salmon-colored plaques...

Author:: Nicholas D. Brownstone, MD; Vidhatha Reddy, BA; Quinn Thibodeaux, MD; Bridget Myers, BS; Stephanie Chan, BS; Wilson Liao, MD; Tina Bhutani, MD

Here, we report 2 patients with AD who were treated with dupilumab and subsequently developed facial flushing after consuming alcohol. A possible...

Author:: Erica B. Lee, BS; Kevin K. Wu, BA; Michael P. Lee, BS; Tina Bhutani, MD; Jashin J. Wu, MD

Numerous factors contribute to the onset and exacerbation of psoriasis. Genetic risk factors include HLA-Cw6 and mutations in the caspase...

Author:: Erica B. Lee, BS; Mina Amin, BS; Tina Bhutani, MD; Jashin J. Wu, MD

Many new biologics are being studied for use in psoriasis. In this review, we evaluate and summarize findings about emerging biologic therapies...

Author:: Mina Amin, BS; Erica B. Lee, BS; Tina Bhutani, MD; Jashin J. Wu, MD

Psoriasis is associated with cardiovascular risk factors and myocardial infarction, but regular physical activity is known to decrease the risk of...

Author:: Mio Nakamura, MD; Michael Abrouk, MD; Benjamin Farahnik, MD; Tian Hao Zhu, MD; Tina Bhutani, MD

The management of psoriatic disease in the human immunodeficiency virus (HIV)–positive population is challenging...